Literature DB >> 19887401

Critical choices in financing the response to the global HIV/AIDS pandemic.

Robert Hecht1, Lori Bollinger, John Stover, William McGreevey, Farzana Muhib, Callisto Emas Madavo, David de Ferranti.   

Abstract

The AIDS pandemic will enter its fiftieth year in 2031. Despite much progress, there are thirty-three million infected people worldwide, and 2.3 million adults were newly infected in 2007. Without a change in approach, a major pandemic will still be with us in 2031. Modeling carried out for the AIDS 2031 project suggests that funding required for developing countries to address the pandemic could reach $35 billion annually by 2031-three times the current level. Even then, more than a million people will still be newly infected each year. However, wise policy choices focusing on high-impact prevention and efficient treatment could cut costs by half. Investments in new prevention tools and major behavior-change efforts are needed to spur more rapid advances. Existing donors, middle-income countries with contained epidemics, philanthropists, and innovative financing could help bridge the likely funding gap.

Entities:  

Mesh:

Year:  2009        PMID: 19887401     DOI: 10.1377/hlthaff.28.6.1591

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  22 in total

Review 1.  Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.

Authors:  Eduard J Beck; Carlos Avila; Sofia Gerbase; Guy Harling; Paul De Lay
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

2.  Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Martha J Bojko; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-06-16

3.  Optimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor Settings.

Authors:  Sulav Duwal; Stefanie Winkelmann; Christof Schütte; Max von Kleist
Journal:  PLoS Comput Biol       Date:  2015-04-30       Impact factor: 4.475

4.  Finding a cure for HIV: will it ever be achievable?

Authors:  Sharon R Lewin; Vanessa A Evans; Julian H Elliott; Bruno Spire; Nicolas Chomont
Journal:  J Int AIDS Soc       Date:  2011-01-24       Impact factor: 5.396

Review 5.  Rethinking prevention of HIV type 1 infection.

Authors:  David N Burns; Carl W Dieffenbach; Sten H Vermund
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

Review 6.  Structural interventions for HIV prevention in the United States.

Authors:  Adaora A Adimora; Judith D Auerbach
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

7.  Resource flows and levels of spending for the response to HIV and AIDS in Belarus.

Authors:  Valentina I Kachan; Alena I Tkachova; Eleanora Gvozdeva; Ilona Urbanovich; Anna Yakusik; Peter Amico; Carlos Avila-Figueroa
Journal:  BMC Res Notes       Date:  2011-07-21

8.  Ethical use of antiretroviral resources for HIV prevention in resource poor settings.

Authors:  Stuart Rennie
Journal:  Dev World Bioeth       Date:  2013-05-31       Impact factor: 2.294

9.  Assessing the population health impact of market interventions to improve access to antiretroviral treatment.

Authors:  Till Bärnighausen; Margaret Kyle; Joshua A Salomon; Brenda Waning
Journal:  Health Policy Plan       Date:  2011-09-13       Impact factor: 3.547

10.  Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics.

Authors:  Stefan Baral; Carmen H Logie; Ashley Grosso; Andrea L Wirtz; Chris Beyrer
Journal:  BMC Public Health       Date:  2013-05-17       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.